Cargando…

High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy

In this study, we tried to explore if xeroderma pigmentosum complementation group-A (XPA) expression is likely a prognostic prediction factor for locally advanced nasopharyngeal carcinoma (NPC) patients treated with platinum-based chemoradiotherapy, which was considered to bring chemotherapy-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Xiang, Hu, Jiali, Han, Hong-yu, Hua, Yi-jun, Zhou, Ling, Shuai, Wen-di, Du, Wu-ying, Kuang, Chun-mei, Chen, Shuai, Huang, Wenlin, Liu, Ran-yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695073/ https://www.ncbi.nlm.nih.gov/pubmed/26156020

Ejemplares similares

BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
por: Kuang, Chun-mei, et al.
Publicado: (2017)

Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
por: Ding, Yuxun, et al.
Publicado: (2021)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020)

Hearing Dysfunction in Xpa-Deficient Mice
por: Shinomiya, Hitomi, et al.
Publicado: (2017)

High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
por: Xu, He, et al.
Publicado: (2018)

DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
por: Feng, Xue, et al.
Publicado: (2018)

Redefining the DNA-Binding Domain of Human XPA
por: Sugitani, Norie, et al.
Publicado: (2014)

Cell migration is impaired in XPA‐deficient cells
por: Takeuchi, Seiji, et al.
Publicado: (2022)

The XPA Protein—Life under Precise Control
por: Krasikova, Yuliya S., et al.
Publicado: (2022)

Combined Ki67 and ERCC1 for prognosis in non-keratinizing nasopharyngeal carcinoma underwent chemoradiotherapy
por: Lu, Ying, et al.
Publicado: (2017)

A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population
por: Gao, Chunhai, et al.
Publicado: (2016)

Association of XPA polymorphism with breast cancer risk: A meta-analysis
por: Zhang, Yunhong, et al.
Publicado: (2018)

Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients
por: Guo, Zhen, et al.
Publicado: (2017)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
por: Haksoyler, Veysel, et al.
Publicado: (2021)

TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts
por: Kucab, Jill E., et al.
Publicado: (2015)

Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis
por: Lien, Ching-Feng, et al.
Publicado: (2022)

A new structural insight into XPA–DNA interactions
por: Hilton, Benjamin, et al.
Publicado: (2014)

Transcriptional consequences of XPA disruption in human cell lines
por: Manandhar, Mandira, et al.
Publicado: (2017)

XPA: DNA Repair Protein of Significant Clinical Importance
por: Borszéková Pulzová, Lucia, et al.
Publicado: (2020)

High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Tian, Yu-Feng, et al.
Publicado: (2017)

Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: A meta-analysis
por: He, Ying, et al.
Publicado: (2023)

Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma
por: Zeng, Qi, et al.
Publicado: (2016)

OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer
por: Zhou, Yi, et al.
Publicado: (2014)

Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD
por: Chiang, Chun-Chi, et al.
Publicado: (2010)

Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2016)

The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
por: Guan, Ying, et al.
Publicado: (2015)

High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma
por: Xu, Ya-Fei, et al.
Publicado: (2015)

Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis
por: Liao, Kuang-Ming, et al.
Publicado: (2016)

PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
por: Chou, Chia-Lin, et al.
Publicado: (2020)

A key interaction with RPA orients XPA in NER complexes
por: Topolska-Woś, Agnieszka M, et al.
Publicado: (2020)

Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study
por: Zhang, Shuai, et al.
Publicado: (2018)

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis
por: Zhang, Yan, et al.
Publicado: (2010)

Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy
por: Muangwong, Pooriwat, et al.
Publicado: (2023)

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
por: Liu, Huai, et al.
Publicado: (2013)

Severe muscle loss during radical chemoradiotherapy for non‐metastatic nasopharyngeal carcinoma predicts poor survival
por: Huang, Xiao, et al.
Publicado: (2019)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study
por: Weng, Jingjin, et al.
Publicado: (2017)

Physical and functional interaction between DDB and XPA in nucleotide excision repair
por: Wakasugi, Mitsuo, et al.
Publicado: (2009)

Pretreatment Photopenia on (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_at77sbtddq62v9v26vpgvcrun6